Literature DB >> 8981417

A thrombin cleavage fragment of apolipoprotein E exhibits isoform-specific neurotoxicity.

M A Marques1, M Tolar, J A Harmony, K A Crutcher.   

Abstract

A 22 kDa fragment of apoE containing a putative cytotoxi domain was identified in postmortem human brain tissue and fresh CSF. This fragment is apparently equivalent to the major apoE thrombin cleavage product. In vitro toxicity assays demonstrate that the corresponding fragment derived from recombinantly expressed human apoE is toxic to primary neurons in culture and that the E4-derived fragment is significantly more toxic than the fragment derived from the E3 isoform. These results suggest that proteolytic fragments of apoE may play a direct role in the pathology associated with AD and other diseases in which apoE has been implicated.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8981417     DOI: 10.1097/00001756-199611040-00025

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  28 in total

1.  Truncated apolipoprotein E (ApoE) causes increased intracellular calcium and may mediate ApoE neurotoxicity.

Authors:  M Tolar; J N Keller; S Chan; M P Mattson; M A Marques; K A Crutcher
Journal:  J Neurosci       Date:  1999-08-15       Impact factor: 6.167

2.  Neurotoxicity of the 22 kDa thrombin-cleavage fragment of apolipoprotein E and related synthetic peptides is receptor-mediated.

Authors:  M Tolar; M A Marques; J A Harmony; K A Crutcher
Journal:  J Neurosci       Date:  1997-08-01       Impact factor: 6.167

3.  Expression of human apolipoprotein E4 in neurons causes hyperphosphorylation of protein tau in the brains of transgenic mice.

Authors:  I Tesseur; J Van Dorpe; K Spittaels; C Van den Haute; D Moechars; F Van Leuven
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

4.  Molecular Mechanisms of the R61T Mutation in Apolipoprotein E4: A Dynamic Rescue.

Authors:  Benfeard Williams; Marino Convertino; Jhuma Das; Nikolay V Dokholyan
Journal:  Biophys J       Date:  2017-09-12       Impact factor: 4.033

Review 5.  Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease.

Authors:  Robert W Mahley; Karl H Weisgraber; Yadong Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-27       Impact factor: 11.205

6.  Full-length apolipoprotein E protects against the neurotoxicity of an apoE-related peptide.

Authors:  K A Crutcher; H N Lilley; S R Anthony; W Zhou; V Narayanaswami
Journal:  Brain Res       Date:  2009-10-21       Impact factor: 3.252

7.  Hippocampal infusions of apolipoprotein E peptides induce long-lasting cognitive impairment.

Authors:  Donnie Eddins; Rebecca C Klein; Jerrel L Yakel; Edward D Levin
Journal:  Brain Res Bull       Date:  2009-01-29       Impact factor: 4.077

8.  Apolipoprotein-E forms dimers in human frontal cortex and hippocampus.

Authors:  David A Elliott; Glenda M Halliday; Brett Garner
Journal:  BMC Neurosci       Date:  2010-02-20       Impact factor: 3.288

Review 9.  Progress toward identification of protease activity involved in proteolysis of apolipoprotein e in human brain.

Authors:  Marcos A Marques; Phillip A Owens; Keith A Crutcher
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

10.  Apolipoprotein E-related neurotoxicity as a therapeutic target for Alzheimer's disease.

Authors:  Marcos A Marques; Keith A Crutcher
Journal:  J Mol Neurosci       Date:  2003       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.